Using QALYs in cancer: a review of the methodological limitations. - Wikidata - wikimedia - TriplyDB

Using QALYs in cancer: a review of the methodological limitations.

Using QALYs in cancer: a review of the methodological limitations.

http://www.wikidata.org/entity/Q37877688

about

Current challenges in health economic modeling of cancer therapies: a research inquiry.Using QALYs in telehealth evaluations: a systematic review of methodology and transparency.Calibration of quality-adjusted life years for oncology clinical trials.The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life.Mindfulness for the self-management of fatigue, anxiety, and depression in women with metastatic breast cancer: a mixed methods feasibility study Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values Quality of Life and Cost-Effectiveness of Radiofrequency Ablation versus Open Surgery for Benign Thyroid Nodules: a retrospective cohort study.Health state utilities for skeletal-related events secondary to bone metastases.Associations of cancer and other chronic medical conditions with SF-6D preference-based scores in Medicare beneficiaries.Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.Korean guidelines for pharmacoeconomic evaluation (second and updated version) : consensus and compromise.A review of the psychometric properties of generic utility measures in multiple sclerosis.Impact of novel agents on patient-relevant outcomes in patients with previously untreated chronic lymphocytic leukemia who are not eligible for fludarabine-based therapy.Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments.Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.Health-state utility estimates for health technology assessment: a review of the manufacturers' submissions to the French National Authority for Health.Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval.Health-related Quality of Life in Patients with Metastatic Spinal Cord Compression.Development of an EORTC-8D utility algorithm for Sri Lanka.Cost-Effectiveness of Treatments for the Management of Bone Metastases: A Systematic Literature Review.Effect of early and intensive nutrition care, delivered via telephone or mobile application, on quality of life in people with upper gastrointestinal cancer: study protocol of a randomised controlled trial.

P2860

Q33805471-7527EBF8-4F89-42A1-8494-0C34ED8325D4 Q34042483-5CC751C9-5BE0-4D60-B64C-C7A6EC8F2B37 Q34321847-7D3BCA94-F5DA-4D91-9CC5-551DB7AEBCCC Q34349450-5A695D16-9617-4C33-BC35-245C12C30A35 Q35330774-F7F7FE28-0EC5-432E-9B36-8277C72FE7EC Q36789255-E87D2358-AAD3-4703-81F0-A9E9CD04DD51 Q37163756-17DCA07A-A683-4B68-93AD-F1EA57CF947E Q37278511-82841EED-37C5-4A44-8E25-946862C7433D Q37435228-269913C8-7088-45F2-9591-708F775B8301 Q37470069-1169B0BE-4D34-49BE-AEE1-F8899E3F2A84 Q37610787-9EFD7EEA-4417-41E6-A194-AF0E309B5173 Q37733475-1C376107-21C8-49C7-AA26-B025D3D050AC Q38074370-23D129E6-20A2-470A-AEF9-3171CFF52ABA Q38213347-BF595F93-8925-48E9-9E90-1F325CCA2B87 Q38673560-C31F9AEE-61C6-4B3E-A385-1E801422A598 Q38710744-67CFEF60-9F37-415A-B9CC-89303E2325E5 Q38940841-99B39E67-F70E-49A0-B57B-A3816DF6DE3D Q39108852-9CBB0C22-25DA-4AE5-8500-A39496DA194E Q39198395-1F0E07F6-C725-41AC-8433-62EBECD9616A Q39390977-CA9EFB5E-D824-47C3-AFB0-8321D13495B3 Q44572362-83EBBFA2-87C3-40E3-8F73-194A204A00A6 Q47336507-DCC9A4F3-FDB3-4A09-BB6D-A76F19A0A061 Q55517969-5B2E76AE-C5A4-4440-A996-114F404BCA17

P2860

Using QALYs in cancer: a review of the methodological limitations.

http://www.wikidata.org/entity/Q37877688

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Using QALYs in cancer: a review of the methodological limitations.

@en

Using QALYs in cancer: a review of the methodological limitations.

@nl

type

label

Using QALYs in cancer: a review of the methodological limitations.

@en

Using QALYs in cancer: a review of the methodological limitations.

@nl

prefLabel

Using QALYs in cancer: a review of the methodological limitations.

@en

Using QALYs in cancer: a review of the methodological limitations.

@nl

P1433

Q37877688-1D034A12-1F3D-4BE5-B721-218C74273B8A

P1476

Q37877688-46B6FF3A-2448-4DEE-8B87-7A1BAC304330

P2093

Q37877688-00C52007-F9FC-4D2E-A458-E9118C7757C0

Q37877688-6B3972EA-37B8-46C6-980B-905E4A48231A

Q37877688-C3E0EBD8-4621-4D64-83E8-8956AEB896A7

Q37877688-C89D2DAA-C69B-4622-9119-197FD34AD691

P2860

Q37877688-01C58392-3716-449C-9790-FDE8A35C845B

Q37877688-03E29B1B-3636-488B-95AD-D568C170B7B1

Q37877688-06DF2F98-A0DB-4773-AE75-6C0C7B024A1A

Q37877688-096B2FE6-9463-4058-B64D-C2183F3B16FE

Q37877688-0AF27E71-2C5E-415D-A104-E9BA1734124F

Q37877688-14157AB8-2C1D-479A-8858-0A12B4EA7942

Q37877688-197F012D-56A6-4751-A6F8-75AFE5BD1279

Q37877688-1FB8F8AC-0F64-4463-AB99-A35DBD44CD07

Q37877688-30C5191B-EF75-46BF-AD73-464D53A32F8E

Q37877688-33753E7F-E4D9-4956-A09C-CE3B8CEBA9EA

P2888

Q37877688-7C3EE19A-482C-4632-A769-ED149D736B02

P304

Q37877688-612CD08F-CC33-4D34-9B46-9BE36602132B

P31

Q37877688-410E7B80-209C-4146-81CF-7C535317F5D4

P356

Q37877688-911E5A02-E327-4B67-A3FC-3A826D19D2AE

P433

Q37877688-6B0A2ABD-190C-4F5C-9826-47124D869927

P478

Q37877688-AD79299B-B6F9-4E18-9D5F-0073A8F1C4E2

P50

Q37877688-6A371F35-1F2E-44C8-938C-D1B6A628A7F5

Q37877688-D50A0CE1-1E5B-4724-8441-C53B8A95315B

P577

Q37877688-498C3663-45A2-4418-9AB2-04E8635F3932

P6179

Q37877688-E561F549-DAA1-4C13-B4FB-B09BF8734B27

P698

Q37877688-8C35CB16-4BE9-4BE1-A4FD-F28F169B4702

P356

11588250-000000000-00000

P1433

PharmacoEconomics

P1476

Using QALYs in cancer: a review of the methodological limitations

@en

P2093

Adrian Towse

http://www.w3.org/2001/XMLSchema#string

Koonal K Shah

http://www.w3.org/2001/XMLSchema#string

Michael F Drummond

http://www.w3.org/2001/XMLSchema#string

Qing Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Prospect Theory: An Analysis of Decision under Risk

Reliability and validity of a new scale on internal coherence (ICS) of cancer patients.

Comparative effectiveness and health care spending--implications for reform.

On the (not so) constant proportional trade-off in TTO.

EQ-5D: a measure of health status from the EuroQol Group.

Attitudes toward quality of survival. The concept of "maximal endurable time".

QALYfying the value of life.

Cancer-related fatigue: the scale of the problem.

Use of family proxies in quality of life research for cancer patients at the end of life: a literature review.

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

P2888

11588250-000000000-00000

P304

673-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2165/11588250-000000000-00000

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1026974110

http://www.w3.org/2001/XMLSchema#string

P698

21599035

http://www.w3.org/2001/XMLSchema#string